Journal
MUCOSAL IMMUNOLOGY
Volume 10, Issue 4, Pages 1008-1020Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/mi.2016.100
Keywords
-
Categories
Funding
- NIH/NIAID [R01-AI057020]
- National Institutes of Health [NCI P30 CA0933730, NIH NCRR C06-RR12088, S10-RR12964, S10-RR026825, S10-OD018223-01A1]
- James B. Pendleton Charitable Trust
Ask authors/readers for more resources
The gastrointestinal mucosa is an important site of HIV acquisition, viral replication, and pathogenesis. Immune cells in mucosal tissues frequently differ in phenotype and function from their non-mucosal counterparts. Although perforin-mediated cytotoxicity as measured in blood is a recognized correlate of HIV immune control, its role in gastrointestinal tissues is unknown. We sought to elucidate the cytotoxic features of rectal mucosal CD8(+) T-cells in HIV infected and uninfected subjects. Perforin expression and lytic capacity were significantly reduced in rectal CD8(+) T-cells compared with their blood counterparts, regardless of HIV clinical status; granzyme B (GrzB) was reduced to a lesser extent. Mucosal perforin and GrzB expression were higher in participants not on antiretroviral therapy compared with those on therapy and controls. Reduction in perforin and GrzB was not explained by differences in memory/effector subsets. Expression of T-bet and Eomesodermin was significantly lower in gut CD8(+) T-cells compared with blood, and in vitro neutralization of TGF-beta partially restored perforin expression in gut CD8(+) T-cells. These findings suggest that rectal CD8(+) T-cells are primarily non-cytotoxic, and phenotypically shaped by the tissue microenvironment. Further elucidation of rectal immune responses to HIV will inform the development of vaccines and immunotherapies targeted to mucosal tissues.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available